BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23640125)

  • 1. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
    Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
    J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
    Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D
    Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.
    Férir G; Huskens D; Noppen S; Koharudin LM; Gronenborn AM; Schols D
    J Antimicrob Chemother; 2014 Oct; 69(10):2746-58. PubMed ID: 24970741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development.
    François KO; Auwerx J; Schols D; Balzarini J
    Mol Pharmacol; 2008 Aug; 74(2):330-7. PubMed ID: 18474667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions.
    Auwerx J; François KO; Vanstreels E; Van Laethem K; Daelemans D; Schols D; Balzarini J
    Antiviral Res; 2009 Jul; 83(1):61-70. PubMed ID: 19514109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications.
    Férir G; Petrova MI; Andrei G; Huskens D; Hoorelbeke B; Snoeck R; Vanderleyden J; Balzarini J; Bartoschek S; Brönstrup M; Süssmuth RD; Schols D
    PLoS One; 2013; 8(5):e64010. PubMed ID: 23724015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.
    Balzarini J; Hatse S; Vermeire K; Princen K; Aquaro S; Perno CF; De Clercq E; Egberink H; Vanden Mooter G; Peumans W; Van Damme E; Schols D
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3858-70. PubMed ID: 15388446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness.
    Mathys L; Balzarini J
    J Antimicrob Chemother; 2014 Mar; 69(3):582-93. PubMed ID: 24144923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
    Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J
    Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles.
    Gordts SC; Renders M; Férir G; Huskens D; Van Damme EJ; Peumans W; Balzarini J; Schols D
    J Antimicrob Chemother; 2015; 70(6):1674-85. PubMed ID: 25700718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
    Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
    Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.
    Pusch O; Kalyanaraman R; Tucker LD; Wells JM; Ramratnam B; Boden D
    AIDS; 2006 Oct; 20(15):1917-22. PubMed ID: 16988512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs).
    Férir G; Vermeire K; Huskens D; Balzarini J; Van Damme EJ; Kehr JC; Dittmann E; Swanson MD; Markovitz DM; Schols D
    Antiviral Res; 2011 Jun; 90(3):200-4. PubMed ID: 21501631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.
    Chang TL; Chang CH; Simpson DA; Xu Q; Martin PK; Lagenaur LA; Schoolnik GK; Ho DD; Hillier SL; Holodniy M; Lewicki JA; Lee PP
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11672-7. PubMed ID: 12972635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of inhibition of HIV-1 infection by small anionic microbicides.
    Vzorov AN; Bozja J; Dixon DW; Marzilli LG; Compans RW
    Antiviral Res; 2007 Jan; 73(1):60-8. PubMed ID: 16949681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Algal lectins as potential HIV microbicide candidates.
    Huskens D; Schols D
    Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.